Axogen, Inc. — Director's Dealing 2014

Jun 4, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2014-05-01

Reporting Person: DeVinney Erick Wayne (VP of Clin. & Trans. Sciences)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-01	Employee Stock Option (right to buy)	$2.86	A	10000	Acquired	2021-05-01	Common Stock (10000)	Direct

Footnotes

F1: All shares pursuant to the employee stock option will be fully vested on May 1, 2018 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on May 1, 2015 (12 months from the option grant date) and an additional 12.5% of the aggregate shares each 6 months thereafter.